GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (ASX:PER) » Definitions » Short Interest

Percheron Therapeutics (ASX:PER) Short Interest


View and export this data going back to 2001. Start your Free Trial

What is Percheron Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Percheron Therapeutics's Short Interest

For the Drug Manufacturers - Specialty & Generic subindustry, Percheron Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Percheron Therapeutics's Short Interest Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Percheron Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where Percheron Therapeutics's Short Interest falls into.



Percheron Therapeutics Business Description

Traded in Other Exchanges
Address
14 Wallace Avenue, LEVEL 1, Toorak, VIC, AUS, 3142
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.

Percheron Therapeutics Headlines

No Headlines